PMC5576975_01
Left side the mass upon diagnosis and right side after 7 days of 200 mg pembrolizumab administration.
gr1.jpg
PMC5576975_01_gr1.jpg
fig1
A 65 year old man was diagnosed with lung adenocarcinoma with fine needle biopsy 18G needle from a large mass on the right upper lobe (Fig. 1). Indeed, a new CT of the thorax revealed that the lung mass had become an abscess (Fig. 1).
BioCare: left side X 40 magnification, middle X 200 magnification and right side X 400 magnification.
gr2.jpg
PMC5576975_01_gr2.jpg
fig2
Programmed death-ligand 1 expression however was 100% with DAKO and 95% with the "BioCare" (Fig. 2, Fig. 3).
PMC5576975_02
Left side the mass upon diagnosis and right side after 7 days of pembrolizumab 200 mg administration.
gr4.jpg
PMC5576975_02_gr4.jpg
fig4
A 55 year old man was diagnosed with lung adenocarcinoma with a Pentax convex-probe endobronchial ultrasound (EBUS) right hemithorax paratracheal (Fig. 4, Fig. 5, Fig. 6). Moreover a previous lesion on the left lung remained the same (24mm) (Fig. 4, Fig. 5, Fig. 6).
Elastography upon diagnosis with a strain ration of 0.07%.
gr6.jpg
PMC5576975_02_gr6.jpg
fig6
A 55 year old man was diagnosed with lung adenocarcinoma with a Pentax convex-probe endobronchial ultrasound (EBUS) right hemithorax paratracheal (Fig. 4, Fig. 5, Fig. 6). Moreover a previous lesion on the left lung remained the same (24mm) (Fig. 4, Fig. 5, Fig. 6).
BioCare: left side X 10 magnification, middle: X 40 magnification, right side: X 400 magnification.
gr7.jpg
PMC5576975_02_gr7.jpg
fig7
The patient was stage IV with bone metastasis and he did not have EGFR or ALK mutations, however; he had programmed death-ligand 1 expression 100% with DAKO and 90% with BioCare (Fig. 7, Fig. 8).